Brief: Nexalin Announces Pivotal Halo™ Clarity Trial
24/02/2026 13:22
Feb 24 (Reuters) - Nexalin Technology Inc NXL.O :
* NEXALIN ANNOUNCES PIVOTAL HALO™ CLARITY TRIAL TO SUPPORT
PLANNED
DE NOVO FDA SUBMISSION TARGETING MULTI-BILLION-DOLLAR INSOMNIA
MARKET
Source text: ID:nGNX9LYsc5
Further company coverage: NXL.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Nexalin Technology
See all newsBrief: Nexalin Technology Regains Compliance With Nasdaq Minimum Bid Price Requirement Nasdaq Hearings Panel Grants Request For Continued Listing
NASDAQ RESUMED AT 12:48 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM
NASDAQ RESUMED AT 10:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM